Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
4 hedge funds and large institutions have $3.39M invested in Viking Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
82% more capital invested
Capital invested by funds: $1.86M → $3.39M (+$1.53M)
0% more funds holding
Funds holding: 4 → 4 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$164K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
William Blair & Company
Chicago,
Illinois
| $1.77M | -$164K | -15,740 | -12% |
|
|
PWAM
2
Park West Asset Management
San Francisco,
California
| $1.53M | – | – | – |
|
3
US Bancorp
Minneapolis,
Minnesota
| $48K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $45K | -$23.5K | -2,248 | -44% |
|
VKTXW Hedge Fund Activity: Q3 2018 in Review
4 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q3 2018, worth a combined $3.39M — up 82% from $1.86M a quarter earlier.
Fund positioning in VKTXW was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was William Blair & Company, cutting an estimated $164K.
- 4 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $3.39M of Viking Therapeutics, Inc. stock for Q3 2018, up 82% quarter-over-quarter.
- 0 funds opened new Viking Therapeutics, Inc. positions in Q3 2018 and 0 closed out.
- The largest Viking Therapeutics, Inc. seller in Q3 2018 was William Blair & Company, an estimated $164K sold.
Based on aggregated 13F filings for Q3 2018.